Literature DB >> 18186018

Comparative proteomics and correlated signaling network of rat hippocampus in the pilocarpine model of temporal lobe epilepsy.

Xin-Yu Liu1, Jin-Liang Yang, Li-Juan Chen, Ying Zhang, Ming-Li Yang, Yong-Yang Wu, Fu-Qiang Li, Ming-Hai Tang, Shu-Fang Liang, Yu-Quan Wei.   

Abstract

In temporal lobe epilepsy (TLE), the seizure origin typically involves the hippocampal formation. The pilocarpine-induced TLE provides a model to investigate the molecular and functional characterization of epileptogenesis by mimicking the human epileptic condition. Here, we employed a 2-D gel-based proteomic technique to profile proteome changes in the rat hippocampus after pilocarpine treatment. Using MALDI MS and MS/MS, 57 differentially expressed proteins were identified, which were found either up-regulated and/or down-regulated at the two time points 12 h (acute period; Ap) and 72 h (silent period; Sp) compared with the control. These proteins can be related to underlying mechanism of pilocarpine-induced TLE, indicating cytoskeleton modification, altered synaptic function, mitochondrial dysfunction, changed ion channel, and chaperone. Five of the identified proteins, synaptosomal-associated protein 25 (SNAP25), synapsin-2 (SYN2), homer protein homolog 2 (HOMER2), alpha-internexin (INA), and voltage-dependent anion channel 2 (VDAC2) were investigated by semiquantitative RT-PCR, and SNAP25 and INA were further validated by Western blot and immunohistochemistry staining. Furthermore, association of these pilocarpine-induced proteins with biological functions using the Ingenuity Pathway Analysis (IPA) tool showed that nucleic acid metabolism, system development, tissue and cell morphology were significantly altered. IPA of the canonical networks indicated that six membrane proteins (e.g., SNAP25, SYN2, and HOMER2) participated in three biological networks as starting proteins. Our results offer a clue to identify biomarkers for the development of pharmacological therapies targeted at epilepsy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18186018     DOI: 10.1002/pmic.200700514

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  16 in total

1.  Cooperative regulation of neurotransmitter release by Rab3a and synapsin II.

Authors:  William L Coleman; Maria Bykhovskaia
Journal:  Mol Cell Neurosci       Date:  2010-03-23       Impact factor: 4.314

2.  Human and rodent temporal lobe epilepsy is characterized by changes in O-GlcNAc homeostasis that can be reversed to dampen epileptiform activity.

Authors:  Richard G Sánchez; R Ryley Parrish; Megan Rich; William M Webb; Roxanne M Lockhart; Kazuhito Nakao; Lara Ianov; Susan C Buckingham; Devin R Broadwater; Alistair Jenkins; Nihal C de Lanerolle; Mark Cunningham; Tore Eid; Kristen Riley; Farah D Lubin
Journal:  Neurobiol Dis       Date:  2019-01-06       Impact factor: 5.996

3.  Intermittent hypercapnic hypoxia induced protein changes in the piglet hippocampus identified by MALDI-TOF-MS.

Authors:  Samantha Tang; Rita Machaalani; Mohammad A Kashem; Izuru Matsumoto; Karen A Waters
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

4.  The impact of postsynaptic density 95 blocking peptide (Tat-NR2B9c) and an iNOS inhibitor (1400W) on proteomic profile of the hippocampus in C57BL/6J mouse model of kainate-induced epileptogenesis.

Authors:  Karen Tse; Dean Hammond; Deborah Simpson; Robert J Beynon; Edward Beamer; Michael Tymianski; Michael W Salter; Graeme J Sills; Thimmasettappa Thippeswamy
Journal:  J Neurosci Res       Date:  2019-05-15       Impact factor: 4.164

Review 5.  Identifying targets for preventing epilepsy using systems biology.

Authors:  Jeffrey A Loeb
Journal:  Neurosci Lett       Date:  2011-03-04       Impact factor: 3.046

Review 6.  Global expression profiling in epileptogenesis: does it add to the confusion?

Authors:  Yi Yuen Wang; Paul Smith; Michael Murphy; Mark Cook
Journal:  Brain Pathol       Date:  2009-02-24       Impact factor: 6.508

7.  HIV-1-infected astrocytes and the microglial proteome.

Authors:  Tong Wang; Nan Gong; Jianuo Liu; Irena Kadiu; Stephanie D Kraft-Terry; Joshua D Schlautman; Pawel Ciborowski; David J Volsky; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2008-06-28       Impact factor: 4.147

Review 8.  VDAC2-specific cellular functions and the underlying structure.

Authors:  Shamim Naghdi; György Hajnóczky
Journal:  Biochim Biophys Acta       Date:  2016-04-23

9.  Neuroprotective Activity of Grape Seed and Skin Extract Against Lithium Exposure Using Proteomic Research.

Authors:  Ali Mezni; Abdelhafidh Khazri; Olfa Khazri; Ferid Limam; Pascal Cosette; Ezzeddine Aouani
Journal:  Mol Neurobiol       Date:  2016-03-21       Impact factor: 5.590

10.  Increased oxidative stress and impaired antioxidant response in Lafora disease.

Authors:  Carlos Romá-Mateo; Carmen Aguado; José Luis García-Giménez; José Santiago Ibáñez-Cabellos; Marta Seco-Cervera; Federico V Pallardó; Erwin Knecht; Pascual Sanz
Journal:  Mol Neurobiol       Date:  2014-05-17       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.